Stevens Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Stevens Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,311	Closed	-$225K	–	940
2018 Q4	$225K	Buy	+2,311	New	+$303K	0.01%	614
2018 Q2	–	Sell	-2,953	Closed	-$333K	–	1035
2018 Q1	$333K	Buy	+2,953	New	+$371K	0.01%	591
2017 Q2	–	Sell	-3,148	Closed	-$381K	–	1148
2017 Q1	$381K	Buy	+3,148	New	+$386K	0.01%	649
2016 Q3	–	Sell	-3,025	Closed	-$277K	–	1225
2016 Q2	$277K	Buy	+3,025	New	+$255K	0.01%	702
2015 Q2	–	Sell	-3,521	Closed	-$321K	–	1315
2015 Q1	$321K	Sell	3,521 -817	-19%	-$66.3K	0.01%	724
2014 Q4	$294K	Buy	+4,338	New	+$317K	0.01%	728

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Stevens Capital Management's GWPH Position: Q1 2019 in Review

Stevens Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2019, closing a stake of 2,311 shares — an estimated $225K sold.

Stevens Capital Management first reported a position in GWPH in Q4 2014 and held it in 6 quarters. The position peaked at $381K in Q1 2017. 320 funds tracked by Wall St. Rank hold GWPH as of Q1 2019.

Stevens Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
Stevens Capital Management sold 2,311 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2019, an estimated $225K.
Stevens Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 6 quarters.
Stevens Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $381K in Q1 2017.
320 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2019.

Based on Stevens Capital Management's 13F filing for Q1 2019, filed 3 May 2019.